Hosted on MSN10mon
Researchers find B cells drive responses of other immune cells, can be modified to prevent multiple sclerosis symptomsresearchers used both human samples and mouse models of MS to show that not only does the cytokine signaling between B cells and T cells go awry in MS, but also that B cells of MS patients produce ...
An Australian startup has unveiled the world’s first commercial biologic. Melbourne-based Cortical Labs launched the CL1 at ...
Scaling up biohybrid robots has been difficult due to the weak contractile force of lab-grown muscles, the risk of necrosis in thick muscle tissues, and the challenge of integrating biological ...
We focused on developing fully human scFv CARs for CD19 as a target because CARs with murine scFvs are effective in inducing remissions in patients with relapsed and refractory B-cell malignancies.
Being fruitful, they multiply into a ball of many cells, a shimmering sphere of human potential. Scientists have long dreamed of plucking those naive cells from a young human embryo and coaxing ...
SEATTLE, March 17, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today reported financial results ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results